Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics and Safety of BMS-663068 in HIV-1 Infected Subjects
NCT01009814Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Nov 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fostemsavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Nov 2009; status: completed.
02
Drugs
fostemsavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01009814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009814.